The challanges are many for a small, public company developing its own technology on a global market. With guidence and active participation from the Miris Board of Directors, the CEO and Management Team are able to navigate all aspects of the business. Their dedication, knowledge and expertise are instrumental in ensuring Miris reaches it potential.
"It is a privilege to be part of the development of future individual nutrition for preterm neonates by the engagement in the BoD of Miris Holding."
Work outside of Miris
Independent consultant for Ingemar Kihlström AB, in the life science area.
Short history
Associate professor at Uppsala University. More than 15 years of experience in pharmaceutical and business development for Astra and Pharmacia. Ten years of experience in financing as well as analyst and corporate advisor in life sciences. Chairman of the Board at Artimplant AB, MedCap AB, Prolight Diagnostics AB, Karocell Tissue Engineering, Acromed AB, member of the board at companies in several Nordic countries
Shares in Miris Holding AB: 8 672 265 shares, 2 890 755 options
There was an error trying to send your message.
Please try again later.
Or send as an e-mail to info@mirissolutions.com.
There was an error trying to send your message.
Please try again later.
Or send as an e-mail to order@mirissolutions.com.
There was an error trying to send your message.
Please try again later.
Or send as an e-mail to support@mirissolutions.com.
